Chlorpropamide-induced immune hemolytic anemia.
D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000276:immunology / Q000628:therapy; D000906:Antibodies / Q000032:analysis; D001803:Blood Transfusion; D002747:Chlorpropamide / Q000009:adverse effects*; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D003165:Complement System Proteins; D003298:Coombs Test; D003429:Cross Reactions; D006457:Hemoglobinuria, Paroxysmal / Q000097:blood; D006461:Hemolysis; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis
D000906:Antibodies; D007074:Immunoglobulin G; D003165:Complement System Proteins; D002747:Chlorpropamide